COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Dr. Sean McCarthy, PhD, will speak at the Duke Beijing Healthcare Forum.
News | 05. 26. 2007
